Bellicum Appoints Senior Vice President Of Manufacturing
This article was originally published in Scrip
Bellicum Pharmaceuticals Inc. has appointed Alan K. Smith as senior vice president of manufacturing. Most recently, Smith was vice-president of research and development and cellular therapeutics at an organ procurement organization and tissue bank, LifeNet Health and its wholly owned subsidiary, The Institute of Regenerative Medicine. Previously, Smith was also president and CEO of Cognate BioServices Inc. and was chief operating officer and senior vice president of research and development at Osiris Therapeutics.
You may also be interested in...
How to make the most of the wealth of raw data in pharmaceutical R&D is an increasing challenge for the industry. The digital revolution is already having an impact in areas like clinical trials, and pharma is also starting to embrace new technologies in drug discovery.
Technology advancement has brought a wave of change in healthcare, with an increasing number of key pharma players now recognizing the potential of digital – particularly in clinical trials.
This week's roundup includes high-level appointments by Five Prime Therapeutics, Depomed and Gilead Sciences and board appointments by Verseon, Arix Bioscience, and Corbus Pharmaceuticals.